超500亿美元授权交易带火创新药企:有的市值重回千亿,多家股价翻倍

第一财经
12 Jun

在投资人与创新药企交流过程中,对外授权进展已成为绕不开的话题。“创新药进入收获周期了,毕竟之前一直在投入研发,现在陆续取得积极的数据,实现对外授权交易或上市销售。”一位创新药企人士对记者说。在二级市场上,对于创新药企股价而言,对外授权交易似乎可以起到“点石成金”的效果。今年以来,创新药概念股赚钱效应重现,有药企在对外授权预期笼罩下,市值重回千亿港元;有药企在达成对外授权交易的当天,股价暴涨三成多。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10